Raymond James Financial Inc

Raymond James Financial maintains a capital structure characterized by total assets of $91.94 billion and total equity of $12.57 billion as of Q2 2026. The firm reports a debt-to-equity ratio of 0.0, indicating a conservative leverage profile relative to its equity base. Liquidity is supported by cash and equivalents of $11.22 billion, which represents approximately 12% of total assets. The current ratio is not explicitly provided in the valuation snapshot, but the substantial cash position relative to liabilities suggests adequate short-term solvency. Operating cash flow stands at $1.09 billion, while free cash flow is $998 million, reflecting disciplined capital expenditure of $91 million. The market capitalization is $33.26 billion, trading at a price-to-book ratio of 3.09 and a price-to-tangible book ratio of 3.07.

Profitability metrics indicate a return on equity (ROE) of 16.99% and a return on assets (ROA) of 2.32% for the latest period. The price-to-earnings ratio is 15.58, suggesting the market values the company's earnings at a moderate premium. Revenue for the quarter reached $8.44 billion, with net income of $1.11 billion, resulting in a net margin of approximately 13.1%. Without specific cohort median data provided in the input, direct comparative analysis against sector peers is limited, but the ROE exceeds typical banking sector averages, indicating efficient use of shareholder equity. The enterprise value-to-revenue multiple of 1.39 reflects a valuation consistent with stable financial services firms.

The company's revenue mix is not detailed in segment-specific breakdowns within the provided data, but the business activity is described as commercial banking and investment services. Geographic exposure is not explicitly quantified in the input, limiting the ability to assess regional concentration risks. The firm operates through a diversified set of services including investment advisory, banking, and insurance, which likely contributes to revenue stability. The absence of detailed segment data prevents a granular analysis of revenue concentration by product line or region.

Growth trajectory analysis is constrained by the absence of historical period data in the input. The current quarter's revenue of $8.44 billion and net income of $1.11 billion provide a baseline for performance, but year-over-year or multi-year trends cannot be calculated from the available information. The share count remains relatively stable, with 194.64 million basic shares and 200.30 million diluted shares outstanding. The difference between basic and diluted shares suggests the presence of stock-based compensation or other dilutive instruments, which is consistent with the medium dilution risk assessment.

Risk assessment highlights a low liquidity risk but a medium dilution risk. Key flags indicate that source documents mention dilution or offering risk, which may stem from stock-based compensation plans or potential equity offerings. The filing observations note that counterparties to derivative instruments could terminate agreements and request immediate payment if debt falls below investment-grade or if the company defaults. This introduces a contingent liability risk tied to credit ratings and derivative positions. The company pledges bank loans and available-for-sale securities as collateral for borrowings, which could impact liquidity in stress scenarios.

Recent events include an 8-K filing with material items related to item 2.02, which typically involves results of operations and financial condition. The filing severity is assessed as medium. Analyst estimates show a mean price target of $184.76, with a median of $179.33, indicating a potential upside from the current market price of $166.06. The mean recommendation is 2.53, suggesting a neutral to slightly positive sentiment among analysts. The high price target of $205.00 and low of $161.00 reflect a range of expectations, with the current price near the lower end of this spectrum.

Raymond James Financial Inc (RJF) has experienced significant institutional activity, marked by major modifications in shareholdings for two distinct investors as of the March 31, 2026 reporting period. These changes, detected in late June 2026, represent the first analyzed data points for the ticker, establishing a new baseline for ownership tracking. The most prominent shift involves Investor ID 587, who adjusted their position from a negligible 793 shares to a substantial holding of 493,475 shares, valued at approximately $71.45 million. This move increased the investor's weight in the company to 0.041%, signaling a decisive entry into the firm's shareholder base. Concurrently, Investor ID 931 executed a similar accumulation strategy, increasing their stake from 190 shares to 258,719 shares. This position, valued at roughly $36.56 million, accounts for a 0.018% weight in RJF. Both transactions were flagged with "major" severity, highlighting the magnitude of the capital deployment relative to the previous near-zero holdings. The simultaneous nature of these large-scale acquisitions suggests coordinated or independent institutional interest in the financial services provider during the first quarter of 2026. These developments are particularly notable given that this analysis serves as the initial basis for delta computation for RJF, meaning there is no prior historical data within this specific tracking framework to compare against. The company currently maintains a profile with one reported officer, no analyst coverage, and membership in one index, while being held by 36 top holders. The emergence of these two significant new positions adds depth to the ownership structure, potentially influencing future liquidity and governance dynamics. The significance of these changes lies in the establishment of a new ownership baseline for Raymond James Financial Inc. With no prior basis for delta computation in this analysis, the sudden appearance of multi-million-dollar stakes from Investors 587 and 931 marks a pivotal moment in the company's recent institutional footprint. As the first recorded major holder changes, these events set the stage for future monitoring of institutional sentiment and capital flows into RJF, providing critical context for understanding the firm's evolving investor relations landscape.

Raymond James generates a best-in-class 16.99% ROE, significantly outperforming the 6.44% median for the broader bank cohort.

Analysts project 10.2% upside to a mean price target of $174.60, indicating positive market sentiment for the stock.

The company achieved a 9.0% net income CAGR from FY2023 to FY2025, demonstrating consistent long-term profitability growth.

Raymond James maintains a zero debt-to-equity ratio, ranking in the top quartile for financial leverage within its peer group.

Free cash flow improved significantly to $1.95 billion in FY2024, reversing the negative trend seen in the prior fiscal year.

Revenue declined 6.2% year-over-year in FY2025, signaling a contraction in top-line growth momentum for the period.

Total assets decreased by 5.9% year-over-year in FY2025, reflecting a shrinking balance sheet relative to the prior period.

Equity declined 6.6% year-over-year in FY2025, indicating a reduction in shareholder capital during the reported period.

The company faces medium dilution risk, which could negatively impact per-share value and existing shareholder ownership stakes.

Revenue $8.44B; Net margin 13.1%.

• ▍Revenue $8.44B
• ▍Net margin 13.1%

Revenue $4.18B; Net margin 13.5%.

• ▍Revenue $4.18B
• ▍Net margin 13.5%

Revenue $15.91B; Net margin 13.4%.

• ▍Revenue $15.91B
• ▍Net margin 13.4%

Revenue $14.92B; Net margin 13.9%.

• ▍Revenue $14.92B
• ▍Net margin 13.9%

Revenue $14.92B; Net margin 13.9%.

• ▍Revenue $14.92B
• ▍Net margin 13.9%

Revenue $12.99B; Net margin 13.4%.

• ▍Revenue $12.99B
• ▍Net margin 13.4%

Revenue $12.99B; Net margin 13.4%.

• ▍Revenue $12.99B
• ▍Net margin 13.4%